Sangmo M. Hong

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Behavioral and health-factor domains of Life's Essential 8 in advanced cardiovascular-kidney-metabolic syndrome among Korean adults: a nationally representative cross-sectional analysis.

Behavioral and health-factor domains of Life's Essential 8 in advanced cardiovascular-kidney-metabolic syndrome among Korean adults: a nationally representative cross-sectional analysis.

Journal: Frontiers in endocrinology

Published: June 10, 2026

Appendicular-to-trunk lean mass ratio resolves the height-based normalization paradox in low muscle mass and metabolic syndrome: A population-based cross-sectional study.

Appendicular-to-trunk lean mass ratio resolves the height-based normalization paradox in low muscle mass and metabolic syndrome: A population-based cross-sectional study.

Journal: PloS one

Published: May 24, 2026

Association of Systolic and Diastolic Blood Pressure with the Risk of End-Stage Renal Disease in Older Type 2 Diabetes Mellitus Patients without Cardiovascular Disease: A Nationwide Population-Based Study (Diabetes Metab J 2025;49:1308-17).

Association of Systolic and Diastolic Blood Pressure with the Risk of End-Stage Renal Disease in Older Type 2 Diabetes Mellitus Patients without Cardiovascular Disease: A Nationwide Population-Based Study (Diabetes Metab J 2025;49:1308-17).

Journal: Diabetes & metabolism journal

Published: March 11, 2026

Hypertriglyceridemia in adults with diabetes mellitus in Korea: Sex, age, and lifestyle determinants.

Hypertriglyceridemia in adults with diabetes mellitus in Korea: Sex, age, and lifestyle determinants.

Journal: Journal of clinical lipidology

Published: January 02, 2026

Waist-to-Height Ratio and the Risk of Cardiovascular Outcomes and Mortality in Type 2 Diabetes With and Without Abdominal Obesity.

Waist-to-Height Ratio and the Risk of Cardiovascular Outcomes and Mortality in Type 2 Diabetes With and Without Abdominal Obesity.

Journal: Diabetes, obesity & metabolism

Published: November 30, 2025

Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study).

Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study).

Journal: Diabetes, obesity & metabolism

Published: September 28, 2025

Reduced risk of hepatocellular carcinoma in the use of fibrate as an add-on to statin: A retrospective population-based cohort study.

Reduced risk of hepatocellular carcinoma in the use of fibrate as an add-on to statin: A retrospective population-based cohort study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 25, 2025

From Old to New: A Comprehensive Review of Obesity Diagnostic Criteria and Their Implications.

From Old to New: A Comprehensive Review of Obesity Diagnostic Criteria and Their Implications.

Journal: Endocrinology and metabolism (Seoul, Korea)

Published: August 04, 2025

Effects of cilostazol on the prognosis of lower extremity peripheral arterial disease in patients with diabetes mellitus in Korea: A nationwide population-based study.

Effects of cilostazol on the prognosis of lower extremity peripheral arterial disease in patients with diabetes mellitus in Korea: A nationwide population-based study.

Journal: Atherosclerosis

Published: August 02, 2025

Weight-independent amelioration of adipokine profile by enavogliflozin, a selective SGLT2 inhibitor, in patients with type 2 diabetes.

Weight-independent amelioration of adipokine profile by enavogliflozin, a selective SGLT2 inhibitor, in patients with type 2 diabetes.

Journal: Cardiovascular diabetology

Published: June 25, 2025

Effects of RAS and SGLT2 inhibitors alone or in combination on end-stage kidney disease and/or all-cause death in patients with both diabetes and hypertension: a nationwide cohort study.

Effects of RAS and SGLT2 inhibitors alone or in combination on end-stage kidney disease and/or all-cause death in patients with both diabetes and hypertension: a nationwide cohort study.

Journal: Cardiovascular diabetology

Published: April 09, 2025

Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortality.

Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortality.

Journal: Cardiovascular diabetology

Published: March 26, 2025

Showing 1-12 of 80

Last Updated: 09/26/2026